Description
A classical multitargeted antifolate that inhibits multiple folate-requiring enzymes TS/DHFR/GARFT with Ki of 1.3/7.2/65nM respectively; increases the cytotoxicity and antitumor activity of gemcitabine in HT29 colon carcinoma. Chemotherapeutic Agents Approved